Who is sponsoring NCT03277391?

NCT03277391 is sponsored by Université Libre de Bruxelles.

What drugs are being tested in NCT03277391?

Interventions in NCT03277391: Serratus anterior plane block, patient-controlled analgesia.

What condition does NCT03277391 study?

NCT03277391 studies Regional Anesthesia, Thoracic Surgery, Post-operative Pain, Post-operative Chronic Pain, Pharmacokinetic Analysis, Serratus Anterior Plane Block.

Is NCT03277391 still recruiting?

NCT03277391 is currently status unknown. Last updated 6 September 2017.

Last reviewed 2017-09-06 · How we verify

NCT03277391: Serrathos

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serratus Anterior Plane Block: Post-operative Analgesia Technique in Video-assisted Thoracic Surgery. Efficacy Pilot Study and Population Pharmacokinetic Analysis

Status unknown NA Last updated 6 September 2017

What this trial tests

NA trial testing Serratus anterior plane block in Regional Anesthesia in 20 participants. Status unknown.

Timeline

14 April 2017

Primary endpoint
1 April 2018

1 May 2018

Quick facts

Lead sponsor	Université Libre de Bruxelles
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	14 April 2017
Primary completion	1 April 2018
Estimated completion	1 May 2018
Sites	1 location across Belgium

Drugs / interventions tested

Serratus anterior plane block
patient-controlled analgesia

Conditions studied

Regional Anesthesia — all drugs for Regional Anesthesia →
Thoracic Surgery — all drugs for Thoracic Surgery →
Post-operative Pain — all drugs for Post-operative Pain →
Post-operative Chronic Pain — all drugs for Post-operative Chronic Pain →

Sponsor

Université Libre de Bruxelles — full company profile →

Who can join

Adults 18 to 85, any sex, with Regional Anesthesia or Thoracic Surgery. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Morphine consumption (mg)
Time frame: 24 hours
Consumption of intravenous morphine

Sponsor's own description

The objective of the study is to compare the efficacy of the Serratus Anterior Plane block (SPB) realised in its deep plane, with a multi-holed catheter in place for twenty four hours, to a standard intravenous analgesia for small videoassisted thoracic surgery interventions. The objective is also to evaluate the resorption rate of local anesthetic at this level, and make a population pharmacokinetic analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Serratus anterior plane block

Trials testing the same drug.

NCT06340880 — Serratus Anterior Plane Block, Ultrasound vs Anatomical Landmark Guided. · completed
NCT05958823 — Effects of Serratus Anterior Plane Block (SAP), Pectoral Nerve Blocks (PECS I-II), and Standard Systemic Analgesia on Ea · NA · completed
NCT05772533 — Serratus Anterior Plane Block Versus Pericapsular Nerve Group Block for Shoulder Surgery · NA · completed
NCT05661279 — Rhomboid Intercostal Block Versus Serratus Anterior Plane Block · NA · unknown
NCT05526469 — Ultrasound-Guided Serratus Anterior Plane Block Versus Erector Spinae Plane Block in Pediatric Cardiac Surgery · NA · completed

Other recruiting trials for Regional Anesthesia

Currently open trials in the same condition.

NCT07452120 — DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery · NA · recruiting
NCT07326644 — Effect of Gestational Weight Gain on Spinal Anesthesia in Elective Cesarean Delivery · recruiting
NCT07445854 — Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques · recruiting
NCT07221903 — The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA · recruiting
NCT07176494 — Revision of Deep Brain Stimulator in Patients With Parkinson's Disease · NA · recruiting

Other Université Libre de Bruxelles trials

Trials by the same sponsor.

NCT07568405 — The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold · NA · enrolling by invitation
NCT07513974 — Objective Measurement of the Mechanical Pain Threshold With an Algometer for Predicting Intraoperative Opioid Consumptio · NA · recruiting
NCT07236021 — e-Motion : Promoting Emotion Regulation in Chronic Cancer · NA · recruiting
NCT06959069 — Impact of Intermittent Fasting on Sleep and Quality of Life · NA · recruiting
NCT06666101 — Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03277391 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université Libre de Bruxelles
Last refreshed: 6 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03277391.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing